MPN-375 BET Inhibitor Pelabresib (CPI-0610) Combined With Ruxolitinib in Patients With Myelofibrosis – JAK Inhibitor-Naïe or With Suboptimal Response to Ruxolitinib – Preliminary Data From the MANIFEST Study

John Mascarenhas, Marina Kremyanskaya, Andrea Patriarca, Claire Harrison, Prithviraj Bose, Raajit K. Rampal, Francesca Palandri, Timothy Devos, Francesco Passamonti, Gabriela Hobbs, Moshe Talpaz, Alessandro Vannucchi, Jean Jacques Kiladjian, Srdan Verstovsek, Ron Hoffman, Mohamed E. Salama, Dong Chen, Pietro Taverna, Alex Chang, Gozde ColakSandra Klein, Vikas Gupta

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'MPN-375 BET Inhibitor Pelabresib (CPI-0610) Combined With Ruxolitinib in Patients With Myelofibrosis – JAK Inhibitor-Naïe or With Suboptimal Response to Ruxolitinib – Preliminary Data From the MANIFEST Study'. Together they form a unique fingerprint.

Medicine & Life Sciences